Bristol Myers Squibb (BMY) Retained Earnings (2009 - 2026)
Bristol Myers Squibb (BMY) reported Retained Earnings of -$1.4 billion for Q1 2026, down 108.51% year-over-year from $16.1 billion in Q1 2025, and up 10.1% on a QoQ basis from -$1.5 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Retained Earnings data on file, last reported at -$1.4 billion in Q1 2026.
- Quarterly Retained Earnings fell 108.51% year-over-year to -$1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 108.51% YoY) and the FY2025 annual result came in at -$1.5 billion, down 23.1% from the prior year.
- Retained Earnings grew to -$1.4 billion in Q1 2026 per BMY's latest filing, from -$1.5 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $25.5 billion in Q4 2022 and bottomed at -$1.6 billion in Q2 2025.
- The 5-year median for Retained Earnings is -$1.2 billion (2024), against an average of $7.4 billion.
- The widest annual swing landed in 2024, when Retained Earnings soared 1351.71%; it then slumped 108.51% in 2026.
- Tracing BMY's Retained Earnings over 5 years: stood at $25.5 billion in 2022, then slumped by 106.06% to -$1.5 billion in 2023, then climbed by 19.92% to -$1.2 billion in 2024, then decreased by 23.1% to -$1.5 billion in 2025, then gained by 10.1% to -$1.4 billion in 2026.
- Per Business Quant, the three latest BMY Retained Earnings figures stand at -$1.4 billion (Q1 2026), -$1.5 billion (Q4 2025), and $17.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 29.51 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -14.83 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -17.87 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 66.72 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -190.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 78.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -7.20 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.37 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 1.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.37 Bn |
| Dec 31, 2025 | -1.52 Bn |
| Sep 30, 2025 | 17.09 Bn |
| Jun 30, 2025 | -1.55 Bn |
| Mar 31, 2025 | 16.11 Bn |
| Dec 31, 2024 | -1.24 Bn |
| Sep 30, 2024 | 16.10 Bn |
| Jun 30, 2024 | -1.46 Bn |
| Mar 31, 2024 | 15.64 Bn |
| Dec 31, 2023 | -1.55 Bn |
| Sep 30, 2023 | -1.29 Bn |
| Jun 30, 2023 | -1.39 Bn |
| Mar 31, 2023 | -1.37 Bn |
| Dec 31, 2022 | 25.50 Bn |
| Sep 30, 2022 | 24.68 Bn |
| Jun 30, 2022 | 24.22 Bn |
| Mar 31, 2022 | -1.23 Bn |
| Dec 31, 2021 | 23.82 Bn |
| Sep 30, 2021 | 22.63 Bn |
| Jun 30, 2021 | 22.17 Bn |
| Mar 31, 2021 | -1.54 Bn |
| Dec 31, 2020 | 21.28 Bn |
| Sep 30, 2020 | 32.41 Bn |
| Jun 30, 2020 | -1.56 Bn |
| Mar 31, 2020 | 32.67 Bn |
| Dec 31, 2019 | -1.52 Bn |
| Sep 30, 2019 | 36.56 Bn |
| Jun 30, 2019 | -2.62 Bn |
| Mar 31, 2019 | 35.11 Bn |
| Dec 31, 2018 | 34.07 Bn |
| Sep 30, 2018 | -2.33 Bn |
| Jun 30, 2018 | 32.04 Bn |
| Mar 31, 2018 | -2.23 Bn |
| Dec 31, 2017 | -2.29 Bn |
| Sep 30, 2017 | -2.42 Bn |
| Jun 30, 2017 | 33.93 Bn |
| Mar 31, 2017 | -2.41 Bn |
| Dec 31, 2016 | 33.51 Bn |
| Sep 30, 2016 | 33.27 Bn |
| Jun 30, 2016 | 32.71 Bn |
| Mar 31, 2016 | -2.69 Bn |
| Dec 31, 2015 | -2.47 Bn |
| Sep 30, 2015 | 32.45 Bn |
| Jun 30, 2015 | 32.36 Bn |
| Mar 31, 2015 | 33.11 Bn |
| Dec 31, 2014 | -2.43 Bn |
| Sep 30, 2014 | 33.15 Bn |
| Jun 30, 2014 | 33.03 Bn |
| Mar 31, 2014 | 33.29 Bn |
| Dec 31, 2013 | 32.95 Bn |
| Sep 30, 2013 | 32.83 Bn |
| Jun 30, 2013 | 32.72 Bn |
| Mar 31, 2013 | 32.76 Bn |
| Dec 31, 2012 | 32.73 Bn |
| Sep 30, 2012 | 32.38 Bn |
| Jun 30, 2012 | 33.66 Bn |
| Mar 31, 2012 | 33.60 Bn |
| Dec 31, 2011 | 33.07 Bn |
| Sep 30, 2011 | -2.28 Bn |
| Jun 30, 2011 | 32.39 Bn |
| Mar 31, 2011 | 32.06 Bn |
| Dec 31, 2010 | 31.64 Bn |
| Sep 30, 2010 | -2.33 Bn |
| Jun 30, 2010 | -2.30 Bn |
| Mar 31, 2010 | 30.95 Bn |
| Dec 31, 2009 | 30.76 Bn |
| Sep 30, 2009 | 23.29 Bn |
| Jun 30, 2009 | -2.26 Bn |